[LHN]
Subscribe
Open menu
MethodologySubmit a ClaimMedical Disclaimer

Does NMN raise NAD+ and slow aging?

NMN supplements are marketed as NAD boosters that slow aging.

LHN branded editorial cover for claim check: Does NMN raise NAD+ and slow aging?.

Simple answer

NMN may affect NAD-related biomarkers in some studies, but that does not prove it slows human aging. The stronger claim needs clinical outcomes, not only a molecule-level signal. The safer reading is: do not treat social media or clinic marketing as proof, and do not use this page for medical decisions.

Bottom line at a glance

Bottom line:MixedEvidence:Human trial evidenceRisk:Moderate riskStatus:Supplement status
What does evidence mean?
Tested in people in a controlled study.
Why risk matters
There are meaningful uncertainty, interaction or overuse concerns.
Approval status
Sold as a supplement, which is not the same as drug approval.

Last checked: Jun 27, 2026

What people claim

The claim bundles biomarker change with anti-aging benefit.

What we know

  • Human biomarker studies are more relevant than animal-only claims.
  • A biomarker increase is not the same as proven healthspan benefit.
  • Supplement status and jurisdiction-specific rules matter.

What we do not know

  • It does not prove slower aging.
  • It does not prove lifespan extension.
  • It does not prove all products are equivalent.

What should you do with this information?

  • Use it to ask better questions.
  • Look for human evidence, not only exciting mechanisms or popularity.
  • Do not judge a claim by influencer attention or marketing language.

What not to do

  • Do not assume a biomarker change means a health outcome changed.
  • Do not combine supplements or drugs based only on marketing claims.
  • Ask a qualified clinician about interactions, conditions and lab context.

Questions to ask a qualified clinician

  1. What exact medical indication is being discussed, and is it approved for that use?
  2. What human evidence exists for my situation, not just animals, cells or biomarkers?
  3. What monitoring, contraindications and interaction questions matter before any decision?
  4. What outcome would show benefit, and what outcome would show harm or no effect?

Want the deeper version?

Open these sections if you want the source detail, regulatory context and expert notes.

Show the evidenceSources, study type and where the claim gets weaker.+

Weakest link in the claim

  • The weak link is treating NAD change as confirmed aging benefit.
Show regulatory detailApproval status is use-specific. Internet claims may not match reviewed uses.+
Status:Supplement statusWho might profit:Supplement brand
Show expert notesWhat would change our mind, money trail and related claims.+

What would change our mind

  • Longer human trials with clinical endpoints.
  • Better product standardization.
  • Replication in diverse populations.

Money trail

Who might profit:Supplement brand

Commercial context does not automatically make a claim false, but it changes how carefully the claim should be read.

  • NMN claims are often made by supplement brands with direct product incentives.

FAQs

Does this page give a protocol?

No. LHN claim checks explain evidence, risk, regulatory status and source context. They do not provide personal medical instructions.

Does raising NAD+ prove anti-aging benefit?

No. Biomarker shifts need outcome validation.

Related claims

Related guides

Get the weekly longevity evidence briefing.

One plain-English email on the claims, studies and regulatory updates worth knowing - without protocols, hype or miracle claims.

No protocols. No miracle claims. No spam.

Choose your interests